Virus News and Research

Latest Virus News and Research

Experimental Ebola vaccine may help fight latest flare-up in Guinea

Hundreds of people who may have been in contact with 8 individuals infected with Ebola virus in Guinea’s southern prefectures of Nzérékoré and Macenta have been vaccinated with the experimental Ebola vaccine in a bid to contain the latest flare-up of Ebola.

1 Apr 2016

Johns Hopkins expert offers tips on Zika virus relating to pregnancy, sexual transmission

No treatment or vaccine currently exists for Zika virus. For most people who contract the virus, the illness will be mild and pass on its own in about one week.

1 Apr 2016

Purdue University-led researchers determine structure of Zika virus

A team led by Purdue University researchers is the first to determine the structure of the Zika virus, which reveals insights critical to the development of effective antiviral treatments and vaccines.

1 Apr 2016

New Rutgers study links protein that helps fight infection to heart and liver disease

A protein that should help fight infection and keep us healthy may be targeted for treating devastating illnesses like heart and liver disease, according to a new Rutgers study.

31 Mar 2016

FDA announces availability of investigational test to screen donated blood for Zika virus

The U.S. Food and Drug Administration today announced the availability of an investigational test to screen blood donations for Zika virus. The screening test may be used under an investigational new drug application (IND) for screening donated blood in areas with active mosquito-borne transmission of Zika virus.

31 Mar 2016

NHS England to provide crucial funding for Janssen's HIV treatment, REZOLSTA

Janssen-Cilag Ltd today announced that NHS England will provide crucial funding for its once-daily, fixed-dose combination of darunavir and the pharmacoenhancer, cobicistat, called REZOLSTA.

31 Mar 2016

Abstracts on colistin resistance and migrant health part of 300 late-breaker sessions for ECCMID 2016

The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores risks, knowledge sharing and best practices in the fight against infectious disease – has received more than 300 late-breaker abstract submissions for its annual congress, ECCMID 2016 in Amsterdam.

31 Mar 2016

Zika threat to Olympics attendees? An interview with Prof. Eskild Petersen

The risk in terms of the Olympics, especially for travelling populations remains low – with the notable exception of pregnant women.

31 Mar 2016

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

30 Mar 2016

Putative male-determining gene discovery could help develop strategies to combat malaria

A group of scientists, including one from the University of California, Riverside, have discovered a long-hypothesized male determining gene in the mosquito species that carries malaria, laying the groundwork for the development of strategies that could help control the disease.

30 Mar 2016

MedUni Vienna researchers develop new treatment for pre-stages of cervical cancer

Researchers at the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have developed a new treatment for the pre-stages of cervical cancer, caused by human papilloma virus (HPV) infection.

30 Mar 2016

Research describes first new mouse model for Zika infection in decades

Efforts to combat the rapid spread of Zika virus got a boost this week as researchers at the University of Texas Medical Branch, Galveston (UTMB) announced the first peer-reviewed publication of a mouse model for Zika infection reported in decades.

30 Mar 2016

Automated sample-to-answer system could make EVD diagnosis easier

An automated "sample-to-answer" system could provide Ebola virus disease (EVD) diagnosis more quickly and easily than the current standard test, according to research published this week in PLOS Medicine.

30 Mar 2016

UGA and Sanofi Pasteur researchers develop new H1N1 influenza vaccine

Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models.

30 Mar 2016

TSRI study shows hollowed-out version of CPMV could be effective in human therapies

Viruses aren't always bad. In fact, scientists can harness the capabilities of some viruses for good—modifying the viruses to carry drug molecules, for example.

29 Mar 2016

Protease inhibitors may prevent cardiovascular disease risk caused by HIV medications

According to the World Health Organization, approximately 37 million people are living with HIV. Antiviral medications are used to control the disease and prevent its progression to AIDS.

29 Mar 2016

CCN5 protein reverses cardiac fibrosis in heart failure models

CCN5, a matricellular protein, has been found to reverse established cardiac fibrosis in heart failure models, according to a study led by Roger J. Hajjar, MD, Professor of Medicine and Director of the Cardiovascular Research Center at the Icahn School of Medicine at Mount Sinai, and Woo Jin Park, PhD, Professor of Life Sciences at the Gwangju Institute of Science and Technology, South Korea.

29 Mar 2016

Promising UCLA discovery could lead to new method for improving cancer treatments

A promising new discovery by UCLA scientists could lead to a new method of identifying cancer patients that express high levels of an enzyme and are more likely to respond to cancer treatments.

29 Mar 2016

High-throughput RNA interference screen identifies potential drug target against henipaviruses

The closely related Hendra and Nipah viruses (referred to jointly as henipaviruses) are deadly cousins of the more common mumps, measles, and respiratory syncytial viruses, all members of the paramyxovirus family. Henipavirus outbreaks are on the rise, but little is known about them, partly because research has to be conducted under extreme level containment conditions.

28 Mar 2016

Engineered HIV vaccine protein may prevent HIV infection

Some people infected with HIV naturally produce antibodies that effectively neutralize many strains of the rapidly mutating virus, and scientists are working to develop a vaccine capable of inducing such "broadly neutralizing" antibodies that can prevent HIV infection.

28 Mar 2016

Virus News and Research

Latest Virus News and Research

Experimental Ebola vaccine may help fight latest flare-up in Guinea

Johns Hopkins expert offers tips on Zika virus relating to pregnancy, sexual transmission

Purdue University-led researchers determine structure of Zika virus

New Rutgers study links protein that helps fight infection to heart and liver disease

FDA announces availability of investigational test to screen donated blood for Zika virus

NHS England to provide crucial funding for Janssen's HIV treatment, REZOLSTA

Abstracts on colistin resistance and migrant health part of 300 late-breaker sessions for ECCMID 2016

Zika threat to Olympics attendees? An interview with Prof. Eskild Petersen

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Putative male-determining gene discovery could help develop strategies to combat malaria

MedUni Vienna researchers develop new treatment for pre-stages of cervical cancer

Research describes first new mouse model for Zika infection in decades

Automated sample-to-answer system could make EVD diagnosis easier

UGA and Sanofi Pasteur researchers develop new H1N1 influenza vaccine

TSRI study shows hollowed-out version of CPMV could be effective in human therapies

Protease inhibitors may prevent cardiovascular disease risk caused by HIV medications

CCN5 protein reverses cardiac fibrosis in heart failure models

Promising UCLA discovery could lead to new method for improving cancer treatments

High-throughput RNA interference screen identifies potential drug target against henipaviruses

Engineered HIV vaccine protein may prevent HIV infection

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in